Folate-tethered emulsion for the target delivery of retinoids to cancer cells

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 68, Issue 3, 2008, Pages 618-625

  Kim, Sung Hoon ^a   Kim, Jin Ki ^a   Lim, Soo Jeong ^b   Park, Jeong Sook ^c   Lee, Mi Kyung ^d   Kim, Chong Kook ^a  

^a Seoul National University   (South Korea)

^b Sejong University   (South Korea)

^c Chungnam National University   (South Korea)

^d Woosuk University   (South Korea)

Author keywords

All trans retinoic acid; Folate receptor; Folate tethered emulsion; Folic acid

Indexed keywords

FLUORESCENT DYE; FOLIC ACID; LIPID EMULSION; MACROGOL; PHOSPHATIDYLCHOLINE; RETINOIC ACID; SOYBEAN OIL EMULSION;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; BINDING, COMPETITIVE; CELL LINE, TUMOR; EMULSIONS; FOLIC ACID; HUMANS; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; TRETINOIN;

EID: 39849083624     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.08.010     Document Type: Article

References (45)

1. Chawla J.S., and Amiji M.M. Biodegradable poly (ε-caprilactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int. J. Pharm. 249 (2002) 127-138
2. Sapra P., and Allen T.M. Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 42 (2003) 439-462
3. Gabizon A., Shmeeda H., Horowitz A.T., and Zalipsky S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv. Drug Deliv. Rev. 56 (2004) 1177-1192
4. Andresen T.L., Jensen S.S., and Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog. Lipid Res. 44 (2005) 68-97
5. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M.M., and Zalipsky S. Targeting folate receptor with folate linked to extremities of poly (ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug. Chem. 10 (1999) 289-298
6. Lee R.J., and Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269 (1994) 3198-3204
7. Wang S., and Low P.S. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J. Control. Release 53 (1998) 39-48
8. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Shmeeda H., and Zalipsky S. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin. Cancer Res. 9 (2003) 6551-6559
9. Lee R.J., and Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271 (1996) 8481-8487
10. Pan X., and Lee R.J. Tumour-selective drug delivery via folate receptor-targeted liposomes. Expert Opin. Drug Deliv. 1 (2004) 7-17
11. Stevens P.J., Sekido M., and Lee R.J. A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm. Res. 21 (2004) 2153-2157
12. Okamoto C.T. Endocytosis and transcytosis. Adv. Drug Deliv. Rev. 29 (1998) 215-228
13. Sudimack J., and Lee R.J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41 (2000) 147-162
14. Lu Y., and Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54 (2002) 675-693
15. Pan X.Q., Wang H., and Lee R.J. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm. Res. 20 (2003) 417-422
16. Stevens P.J., and Lee R.J. A folate receptor-targeted emulsion formulation for paclitaxel. Anticancer Res. 23 (2003) 4927-4931
17. Montaldo P.G., Pagnan G., Pastorino F., Chiesa V., Raffaghello L., Kirchmeier M., Allen T.M., and Ponzoni M. N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death. Int. J. Cancer 81 (1999) 262-267
18. Estey E.H., Giles F.J., Kantarjian H., O'Brien S., Cortes J., Freireich E.J., Lopez-Berestein G., and Keating M. Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 94 (1999) 2230-2235
19. Hsu S.L., Wu W.S., Tyan Y.S., and Chou C.K. Retinoic acid-induced apoptosis is prevented by serum albumin and enhanced by Lipiodol in human hepatoma Hep3B cells. Cancer Lett. 129 (1998) 205-214
20. Park K.M., and Kim C.K. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int. J. Pharm. 181 (1999) 173-179
21. Hwang S.R., Lim S.J., Park J.S., and Kim C.K. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm. 276 (2004) 175-183
22. Park K.M., Lee M.K., Hwang K.J., and Kim C.K. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int. J. Pharm. 183 (1999) 145-154
23. Furukawa S., Katayama N., Iizuka T., Urabe I., and Okada H. Preparation of polyethylene glycol-bound NAD and its application in a model enzyme reactor. FEBS Lett. 121 (1980) 239-242
24. Zalipsky S., Brandeis E., Newman M.S., Woodle M.C., and circulating L. cation liposomes containing amino-PEG-phosphatidylethanolamine. FEBS Lett. 353 (1994) 71-74
25. Agadir A., Cornic M., Lefebvre P., Gourmel B., Jerome M., Degos L., Fenaux P., and Chomienne C. All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship. J. Clin. Oncol. 13 (1995) 2517-2523
26. Lim S.J., and Kim C.K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int. J. Pharm. 243 (2002) 135-146
27. Parthasarathy R., Sacks P.G., Harris D., Brock H., and Mehta K. Interaction of liposome-associated all-trans-retinoic acid with squamous carcinoma cells. Cancer Chemother. Pharmacol. 34 (1994) 527-534
28. Na K., Park K.H., Kim S.W., and Bae Y.H. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J. Control. Release 69 (2000) 225-236
29. Tachibana R., Harashima H., Shono M., Azumano M., Niwa M., Futaki S., and Kiwada H. Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking. Biochem. Biophys. Res. Commun. 251 (1998) 538-544
30. Orlandi M., Mantovani B., Ammar K., Avitabile E., Dal Monte P., and Bartolini G. Retinoids and cancer: antitumoral effects of ATRA, 9-cis RA and the new retinoid IIF on the HL-60 leukemic cell line. Med. Princ. Pract. 12 (2003) 164-169
31. Ratnam M., Hao H., Zheng X., Wang H., Qi H., Lee R., and Pan X. Receptor induction and targeted drug delivery: a new antileukaemia strategy. Expert Opin. Biol. Ther. 3 (2003) 563-574
32. Leamon C.P., DePrince R.B., and Hendren R.W. Folate-mediated drug delivery: effect of alternative conjugation chemistry. J. Drug Target. 7 (1999) 157-169
33. Shiokawa T., Hattori Y., Kawano K., Ohguchi Y., Kawakami H., Toma K., and Maitani Y. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading acalacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin. Cancer Res. 11 (2005) 2018-2025
34. Muller R.H., and Heinemann S. Fat emulsions for parenteral nutrition I: evaluation of microscopic and laser light scattering methods for the determination of the physical stability. Clin. Nutrit. 11 (1992) 223-272
35. Hong M.S., Lim S.J., Lee M.K., Kim Y.B., and Kim C.K. Prolonged blood circulation of methotrexate by modulation of liposomal composition. Drug Deliv. 8 (2001) 231-237
36. Leamon C.P., Cooper S.R., and Hardee G.E. Folate-liposome-mediated antisense oligodeoxynucleotide targeting cancer cells: evaluation in vitro and in vivo. Bioconjug. Chem. 14 (2003) 738-747
37. Kurlandsky S.B., Gamble M.V., Ramakrishnan R., and Blaner W.S. Plasma delivery of retinoic acid to tissues in the rat. J. Biol. Chem. 270 (1995) 17850-17857
38. Matarese V., and Lodish H.F. Specific uptake of retinol-binding protein by variant F9 cell lines. J. Biol. Chem. 268 (1993) 18859-18865
39. Ward C.M., Pechar M., Oupicky D., Ulbrich K., and Seymour L.W. Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J. Gene Med. 4 (2002) 536-547
40. Arpicco S., Dosio F., Bolognesi A., Lubelli C., Brusa P., Stella B., Ceruti M., and Cattel L. Novel poly(ethylene glycol) derivatives for preparation of ribosome-inactivating protein conjugates. Bioconjug. Chem. 13 (2002) 757-765
41. Klibanov A.L., Maruyama K., Beckerleg A.M., Torchilin V.P., and Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1062 (1991) 142-148
42. Lee R.J., and Low P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1233 (1995) 134-144
43. Elwood P.C. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J. Biol. Chem. 264 (1989) 14893-14901
44. Chung K.N., Saikawa Y., Paik T.H., Dixon K.H., Mulligan T., Cowan K.H., and Elwood P.C. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. J. Clin. Invest. 91 (1993) 1289-1294
45. Saul J.M., Annapragada A., Natarajan J.V., and Bellamkonda R.V. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J. Control. Release 92 (2003) 49-67